OverviewChartNewsTraderScreen

Enzon Pharmaceuticals, Inc./  US2939041081  /

Nasdaq Other OTC
11/6/2024  5:36:04 PM Chg. - Volume Bid- Ask- High Low
0.0850USD - 600
Turnover: 51		 -Bid Size: - -Ask Size: - 0.0850 0.0850
GlobeNewswire 1/24/2022 OTC Markets Group Announces the 2022 OTCQX Best 50
GlobeNewswire 1/6/2021 Silence Therapeutics Appoints Craig Tooman as Chief Financial Officer  
GlobeNewswire 1/4/2021 Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assu...
GlobeNewswire 10/21/2020 Enzon Pharmaceuticals Announces Results of Rights Offering
GlobeNewswire 9/15/2020 Enzon Pharmaceuticals Announces Key Dates for Rights Offering
GlobeNewswire 9/2/2020 Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting
GlobeNewswire 8/21/2020 Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
GlobeNewswire 8/14/2020 Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shar...
GlobeNewswire 1/7/2020 Vyome Therapeutics Strengthens Executive Management with Appointment of Craig Tooman as Chief Operat...
GlobeNewswire 12/12/2019 Translate Bio Announces Executive Leadership Appointments
GlobeNewswire 11/1/2019 Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts E...
GlobeNewswire 9/12/2019 Investigation Report on China's Pegaspargase Market, 2019-2023
GlobeNewswire 6/24/2019 CureVac Welcomes Two Members to its Supervisory Board
GlobeNewswire 3/18/2019 Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Mor...
GlobeNewswire 7/3/2018 Cancer Therapies: World Industry Analysis & Forecasts to 2030 - Key Company Profiles, Emerging Techn...
GlobeNewswire 4/20/2018 Global Malignant Melanoma Drug Market Report 2018: Dosage, Price & Clinical Pipeline Outlook 2024
GlobeNewswire 2/20/2007 Notice of AGM